Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTTX Better Therapeutics	$0.00	$0.00	$0.00 ▼ $0.00	$5K	0.97	15,325 shs	768 shs
OPGN OpGen		$2.88	$0.00 ▼ $0.00	$1K	-1.77	1,028 shs	33 shs
SLHGF Skylight Health Group		$0.00	$0.00 ▼ $0.00	$4K	-0.37	8,707 shs	N/A
UPHL UpHealth	$0.00	$0.00	$0.00 ▼ $0.40	$4K	0.85	5,817 shs	1,343 shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTTX Better Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
OPGN OpGen	0.00%	0.00%	-99.75%	-100.00%	-99.99%
SLHGF Skylight Health Group	0.00%	0.00%	0.00%	0.00%	0.00%
UPHL UpHealth	0.00%	0.00%	0.00%	0.00%	-99.94%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SLHGF Skylight Health Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
UPHL UpHealth	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTTX Better Therapeutics	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A
SLHGF Skylight Health Group	N/A	N/A	N/A
UPHL UpHealth	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	$2.67M	0.00	N/A	N/A	($11.55) per share	0.00
SLHGF Skylight Health Group	$21.67M	0.00	N/A	N/A	N/A	NaN
UPHL UpHealth	$130M	0.00	N/A	N/A	$3.10 per share	0.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTTX Better Therapeutics	-$39.76M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	-$32.67M	N/A	0.00	N/A	N/A	-1,140.36%	N/A	-287.58%	11/13/2025 (Estimated)
SLHGF Skylight Health Group	-$10.97M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
UPHL UpHealth	-$56.42M	-$1.35	N/A	∞	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A	N/A	N/A
SLHGF Skylight Health Group	N/A	N/A	N/A	N/A	N/A
UPHL UpHealth	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTTX Better Therapeutics	N/A	N/A	N/A
OPGN OpGen	N/A	5.45	5.45
SLHGF Skylight Health Group	N/A	N/A	N/A
UPHL UpHealth	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BTTX Better Therapeutics	34.00%
OPGN OpGen	2.68%
SLHGF Skylight Health Group	N/A
UPHL UpHealth	56.10%

Insider Ownership

Company	Insider Ownership
BTTX Better Therapeutics	51.40%
OPGN OpGen	43.80%
SLHGF Skylight Health Group	11.57%
UPHL UpHealth	34.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BTTX Better Therapeutics	40	49.86 million	24.23 million	Optionable
OPGN OpGen	100	10.07 million	4.70 million	Not Optionable
SLHGF Skylight Health Group	260	41.24 million	36.47 million	Not Optionable
UPHL UpHealth	1,750	18.93 million	12.45 million	No Data

SLHGF, BTTX, UPHL, and OPGN Headlines

Recent News About These Companies

UpHealth Delays Q2 2025 10-Q Filing

August 14, 2025 | msn.com

UpHealth, Inc. (UPHL) Latest Stock News & Headlines - Yahoo Finance

April 23, 2025 | finance.yahoo.com

Lemon Dump Cake Recipe

September 9, 2024 | msn.com

DJUSIV Dow Jones US Business Support Services Index

July 27, 2024 | seekingalpha.com

UpHealth Inc Ordinary Shares UPHL

July 19, 2024 | morningstar.comM

UpHealth Holdings, Inc. Wins Ruling in Calcutta High Court, Mandating All Glocal Healthcare Respondents Submit Affidavits of Assets

May 24, 2024 | prnewswire.com

UpHealth, Inc. (UPHL) Advances While Market Declines: Some Information for Investors

April 30, 2024 | zacks.com

UpHealth, Inc. (UPHL)

April 17, 2024 | finance.yahoo.com

Calcutta High Court rules in favour of UpHealth Holdings, Inc., and vigorously reinforces the ICC International Court of Arbitration previous $110 million award against Glocal directors and other Respondents, calling their conduct “dishonest and fraudulent”

April 16, 2024 | finance.yahoo.com

UpHealth Holdings Takes Steps to Enforce the International Court of Arbitration’s Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

April 1, 2024 | finance.yahoo.com

UpHealth, Inc.: UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

March 22, 2024 | finanznachrichten.de

UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

March 21, 2024 | finance.yahoo.com

Healthcare Triangle GAAP EPS of -$1.26, revenue of $7.1M

March 18, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLHGF, BTTX, UPHL, and OPGN Company Descriptions

Better Therapeutics NASDAQ:BTTX

$0.0001 0.00 (0.00%)

As of 08/25/2025 12:36 PM Eastern

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

OpGen NASDAQ:OPGN

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

Skylight Health Group OTCMKTS:SLHGF

Skylight Health Group Inc. operates as a healthcare services and technology company in the United States. The company operates the US multi-state primary care health network, which provides a range of services from primary and urgent care, sub-specialty, allied health and wellness, and laboratory/diagnostic testing. It also provides healthcare services for older and disabled patients. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.

UpHealth NYSE:UPHL

$0.0002 0.00 (0.00%)

As of 03:56 PM Eastern

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time